Preserving Disease Control: The Role of Local Ablative Therapy in EGFR-Mutant NSCLC

Sharareh Gholamin, Matthew Lee, Christine Lovly, Arya Amini

Open source

DOI
10.1016/j.jtho.2026.103958
Published
2026-08
Container
Journal of Thoracic Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtho.2026.103958,
  title = {Preserving Disease Control: The Role of Local Ablative Therapy in EGFR-Mutant NSCLC},
  author = {Sharareh Gholamin and Matthew Lee and Christine Lovly and Arya Amini},
  year = {2026},
  journal = {Journal of Thoracic Oncology},
  doi = {10.1016/j.jtho.2026.103958},
  url = {https://doi.org/10.1016/j.jtho.2026.103958}
}

RIS

TY  - JOUR
TI  - Preserving Disease Control: The Role of Local Ablative Therapy in EGFR-Mutant NSCLC
AU  - Sharareh Gholamin
AU  - Matthew Lee
AU  - Christine Lovly
AU  - Arya Amini
PY  - 2026
JO  - Journal of Thoracic Oncology
DO  - 10.1016/j.jtho.2026.103958
UR  - https://doi.org/10.1016/j.jtho.2026.103958
ER  - 

APA

Gholamin, S., Lee, M., Lovly, C., & Amini, A. (2026). Preserving Disease Control: The Role of Local Ablative Therapy in EGFR-Mutant NSCLC. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2026.103958

Source records